Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial

NCT00268476 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00268476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00268476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial
Lead sponsor
Medical Research Council
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
July 8, 2005
Completion date
December 31, 2030
Enrollment
11,992 (actual)
Sites
120

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer